Skip to main content
Clinical Trials/ISRCTN86192648
ISRCTN86192648
Completed
Phase 3

Trial of the effectiveness and cost effectiveness of selfmonitoring and treatment of blood pressure in secondary prevention following stroke or transient ischaemic attack

orfolk and Norwich University Hospital NHS Trust0 sites156 target enrollmentJune 10, 2015

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Topic: Stroke
Sponsor
orfolk and Norwich University Hospital NHS Trust
Enrollment
156
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

  1. 2018 results in https://www.ncbi.nlm.nih.gov/pubmed/30060882 (added 23/01/2019) 2. 2019 results in https://www.ncbi.nlm.nih.gov/pubmed/30415084 (added 23/01/2019) 3. 2020 economic evaluation in https://www.ncbi.nlm.nih.gov/pubmed/32056146 (added 17/02/2020)
Registry
who.int
Start Date
June 10, 2015
End Date
September 30, 2016
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
orfolk and Norwich University Hospital NHS Trust

Eligibility Criteria

Inclusion Criteria

  • 1\. Age \>\= 55 years
  • 2\. Patients with TIA or stroke of mild/moderate severity (NIHSS \=\<15\)
  • 3\. Patients that require BP management
  • 4\. Patients able and willing to undertake self BP measurement and guided alterations in therapy

Exclusion Criteria

  • 1\. Patients with terminal illness with life expectancy less than six months including end staged condition e.g. end stage COPD Dementia
  • 2\. Patients with moderate to severe cognitive impairment
  • 3\. Patients not receiving or expected to start antihypertensive therapy

Outcomes

Primary Outcomes

Not specified

Similar Trials